Sufentanil

This classification denotes an opioid receptor agonist and opioid with the molecular formula C22H30N2O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AFE2YW0IIZ, chemically known as propanamide, n-(4-(methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-n-phenyl- but generally known as sufentanil, which bears US NIH Compound Identifier 41693. European Medicines Agency schedules Sufentanil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10671MIG. The term SUFENTANIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules sufentanil in its Anatomical Therapeutic Chemical (ATC) Classification. SUFENTANIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule sufentanil under HS 29349100 and SITC 51579. As of Q4 2014, SUFENTANIL remains the US FDA Preferred Term for this commodity. Sufentanil bears US NLM identifiers UMLS ID C0143993 and NCI Concept Code C61956. SMILES: S1C(CCN2CCC(N(C3CCCCC3)C(=O)CC)(CC2)COC)CCC1.